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Effectiveness of Ring Vaccination as 
Control Strategy for Ebola Virus Disease 
Technical Appendix 
Transmission Model 
In the model, transmission followed a branching process, and secondary cases were 
generated from a negative binomial distribution (1,2). We estimated the reproduction number for 
missed cases, Rm, and for cases within a cluster, Rw, by fitting negative binomial distributions (3) 
to data on chains of transmission in Conakry, Guinea, during March–August 2014 (4). The 
distribution of secondary cases in this dataset was enumerated by Althaus (1). Our maximum 
likelihood estimates were Rm = 7 and Rw = 0.66 (Technical Appendix Figure 1, panels A, B). We 
also obtained estimates of the dispersion parameters (Technical Appendix Table 1), which 
suggested that transmission from cases within clusters was highly overdispersed (k = 0.19). This 
estimate indicated that although Rw was small, there was still potential for superspreading events 
within each cluster. As a validation, we also analyzed published data on a transmission chain in 
Liberia, which occurred during December 2014–March 2015 (14). The results were similar: the 
index case had Rm = 5 and the secondary cases generated by nonindex cases had Rw = 0.76 and 
k = 0.82 (Technical Appendix Figure 1, panel C). 
In our transmission model, each cluster started with an index case, which generated 
secondary cases from the fitted negative binomial distribution with average Rm. We assumed 
there was a probability 1 – ρ that each secondary case would remain within the known chain of 
transmission; these cases would then generate an average of Rw secondary cases. If a case was 
missed (with probability ρ), it went on to seed a new cluster as an index case with reproduction 
number Rm. The simulated outbreaks came to an end when no secondary cases were generated by 
the currently active cases. 
In the Conakry transmission scenario, we assumed that incubation period, duration of 
infectiousness, and time from onset to notification were gamma distributed, and had a mean and 
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SD as in the World Health organization patient database for Guinea (5). The duration of 
infectiousness was equal to the time from onset to death (6.4 days). 
In the partial control scenario, we assumed that this was equal to the time from onset to 
hospitalization (5.3 days) because of the increased proportion of cases that would have been 
isolated. Note that these parameters do not affect the number of secondary cases generated by an 
infectious person (which is specified by Rm and Rw), but do affect the duration of the outbreak. 
The incubation period remained unchanged, but the average time from onset to reporting 
decreased 3.6 days, as reported in the 2015 Guinea ring vaccination trial (15). The proportion of 
cases in known chains during this period is shown in Technical Appendix Figure 2. The model 
was implemented in R version 3.1.3 (17). 
Comparison of Overall Reproduction Numbers in Simulated and Real Outbreaks 
To compare our 2 simulated scenarios with transmission dynamics in real Ebola virus 
disease outbreaks, we calculated the overall reproduction number in outbreak simulations. This 
number was defined as the mean number of secondary cases generated across all infectious 
persons. For example, in the transmission chain shown in Figure 1, the overall reproduction 
number R = 0.88. The mean overall reproduction number for the scenarios shown in Figure 2 are 
shown in Technical Appendix Figure 4. As the reproduction number approaches the critical 
value of 1 in Technical Appendix Figure 4, on average transmission will become self-sustaining 
in the model, and thus the probability of observing a large outbreak increases substantially in 
Figure 2. 
When 20%–70% of cases are missed in the model, the overall reproduction number for 
the Conakry scenario ranges between 1 and 2 if outbreaks start with a single initial case in the 
absence of vaccination (Technical Appendix Figure 4, panel A). This finding is consistent with 
estimates of the reproduction number for the West Africa epidemic in early 2014, and with 
estimates of the community reproduction number from the early period of other outbreaks 
(Technical Appendix Table 1). Detailed transmission chain data are not available for historical 
outbreaks, and thus scenarios we consider might not exhibit the same individual variation in 
secondary transmission (as specified by the dispersion parameter k). However, the similarity in 
overall reproduction number suggests that the average transmission dynamics are comparable. 
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However, the crucial difference between pre-2013 outbreaks and the situation in West 
Africa during 2013–2015 is that previously the overall reproduction number decreased 
substantially within weeks rather than over months or years. Thus, our partial control scenario, in 
which the mean overall reproduction number is >1 even without vaccination (Technical 
Appendix Figure 4, panel B) is likely to be more representative of the transmission patterns 
typically faced during earlier EVD outbreaks. 
Ring Vaccination 
During the 2015 Guinea recombinant vesicular stomatitis virus–Zaire Ebola virus vaccine 
trial, ring vaccination was implemented by vaccinating all named contacts of confirmed index 
case-patients, as well as other persons who would have been at risk because of their connections 
to the case-patient; for example, the village of the case-patient, or household contacts of a named 
high-risk contact that lived far from the case-patient (15). In the model, we therefore assumed 
that a randomly sampled proportion of all persons who could form part of the transmission 
cluster (i.e., were not missed) would be vaccinated. 
Once the index case was reported, which depended on the time from onset to reporting, it 
took 2 days for persons to be vaccinated. We assumed that the vaccine became effective after an 
additional 7 days because interim results suggested that no infections were observed in 
vaccinated persons in the Guinea ring vaccination trial after >6 days (15). We also assumed an 
efficacy of 80%, which is toward the lower end of the range given in the interim results from the 
Guinea trial (15). As a sensitivity analysis, we repeated our simulations assuming an efficacy of 
95% (Technical Appendix Figure 5). 
In the trial, 5,415 (71%) of 7,651 contacts were >18 years of age and not pregnant or 
breastfeeding, and thus were eligible for vaccination. Overall, 52% were eligible and consented. 
Because vaccination will in the future likely be expanded to younger age groups, in the model, 
we therefore assumed that a uniformly random sample of 70% of the cluster received the 
vaccine. The reproduction number within a cluster was therefore reduced by a factor (1 – 0.8 × 
0.7) = 0.44 once the vaccine became effective. Thus, the reproduction number was equal to Rw 
before vaccine becomes effective and Rv = 0.44 Rw afterwards. 
We also estimated how many vaccine doses would be required to conduct out such ring 
vaccination. On the basis of the number of persons vaccinated in each cluster in the Guinea 
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recombinant vesicular stomatitis virus–Zaire Ebola virus vaccine trial (15), we specified the 
vaccination ring size to be normally distributed with a mean size of 80 persons and an SD of 20, 
with each new transmission cluster requiring this number of persons to be vaccinated. In the 
partial control scenario, several thousand doses may therefore be required to implement ring 
vaccination (Technical Appendix Tables 2, 3). 
Mass Vaccination 
To introduce mass vaccination in the model, we assumed that 70% of all persons in at-
risk areas were vaccinated; efficacy = 80% (sensitivity analysis with 95% efficacy is shown in  
Technical Appendix Figure 4). This assumption suggests the proportion of the population who 
were susceptible to infection was reduced by a factor of 0.44, regardless of whether they were in 
the cluster or missed. In our branching process model, this assumption was implemented by 
reducing Rm and Rw by a factor of 0.44. When there is 1 initial case, our framework is equivalent 
to the assumption that mass vaccination was performed preemptively before that specific 
outbreak began. When there are several initial cases, we are making the assumption that large-
scale mass vaccination was conducted in the short period between the first case being reported 
and the start point of the simulation, by which multiple initial cases were infected. 
References 
1. Althaus CL. Ebola superspreading. Lancet Infect Dis. 2015;15:507–8. PubMed 
http://dx.doi.org/10.1016/S1473-3099(15)70135-0 
2. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual 
variation on disease emergence. Nature. 2005;438:355–9. PubMed 
http://dx.doi.org/10.1038/nature04153 
3. Delignette-Muller M, Dutang C, Pouillot R, Denis JB. Fitdistrplus package; 2015 [cited 2015 Oct 22]. 
https://cran.r-project.org/package=fitdistrplus 
4. Faye O, Böelle PY, Heleze E, Faye O, Loucoubar C, Magassouba N, et al. Chains of transmission and 
control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study. Lancet Infect 
Dis. 2015;15:320–6. PubMed http://dx.doi.org/10.1016/S1473-3099(15)71075-8 
5. WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic 
and forward projections. N Engl J Med. 2014;371:1481–95. PubMed 
http://dx.doi.org/10.1056/NEJMoa1411100 
 Page 5 of 12 
6. Camacho A, Kucharski AJ, Funk S, Breban J, Piot P, Edmunds WJ. Potential for large outbreaks of 
Ebola virus disease. Epidemics. 2014;9:70–8. PubMed 
http://dx.doi.org/10.1016/j.epidem.2014.09.003 
7. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM. The basic reproductive 
number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J 
Theor Biol. 2004;229:119–26. PubMed http://dx.doi.org/10.1016/j.jtbi.2004.03.006 
8. Ferrari MJ, Bjørnstad ON, Dobson AP. Estimation and inference of R0 of an infectious pathogen by a 
removal method. Math Biosci. 2005;198:14–26. PubMed 
http://dx.doi.org/10.1016/j.mbs.2005.08.002 
9. Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A. Understanding the dynamics of Ebola 
epidemics. Epidemiol Infect. 2007;135:610–21. PubMed 
http://dx.doi.org/10.1017/S0950268806007217 
10. Althaus CL. Estimating the reproduction number of Ebola virus (EBOV) during the 2014 outbreak in 
West Africa, March to August 2014. PLoS Curr. 2014;6:pii: 
ecurrents.outbreaks.91afb5e0f279e7f29e7056095255b288.  
11. Nishiura H, Chowell G. Early transmission dynamics of Ebola virus disease (EVD), West Africa, 
March to August 2014. Euro Surveill. 2014;19:pii: 20894. PubMed 
12. Centre for the Mathematical Modelling of Infectious Diseases. Visualisation and projections of the 
Ebola outbreak in West Africa [cited 2015 Oct 21]. http://cmmid.lshtm.ac.uk/ebola/ 
13. Camacho A, Kucharski AJ, Aki-Sawyer Y, White MA, Flasche S, Baguelin M, et al. Temporal 
changes in Ebola transmission in Sierra Leone and implications for control requirements: a real-
time modelling study. PLoS Curr. 2015;7:pii: 
ecurrents.outbreaks.406ae55e83ec0b5193e30856b9235ed2.  
14. Nyenswah T, Fallah M, Sieh S, Kollie K, Badio M, Gray A, et al. Controlling the last known cluster 
of Ebola virus disease—Liberia, January–February 2015. MMWR Morb Mortal Wkly Rep. 
2015;64:500–4. PubMed 
15. Henao-Restrepo AM, Longini I Jr, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and 
effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results 
from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857–66. PubMed 
http://dx.doi.org/10.1016/S0140-6736(15)61117-5 
 Page 6 of 12 
16. World Health Organization. Weekly epidemiological situation. Ebola outbreak in Guinea: week 20, 
2015 [in French] [cited 2015 Oct 21]. http://guinea-ebov.github.io/sitreps.html 
17. R Core Team. R: a language and environment for statistical computing. Vienna, Austria; 2014 [cited 
2015 Oct 21]. http://www.R-project.org/ 
 
 
Technical Appendix Table 1. Estimates of overall community reproduction number in historical Ebola outbreaks and in early 
stages of the 2013–20515 Ebola virus disease epidemic in West Africa 
Location Date Reproduction no. Reference 
Yambuku, Zaire  1976 1.34 (6) 
Kikwit, Zaire 1995 1.83 (7) 
  3.65 (8) 
  2.7 (9) 
Uganda 2000–2001 1.34 (7) 
  1.79 (8) 
  2.7 (9) 
Guinea 2014 Mar–Aug 1.5 (10) 
 2014 Mar–Aug 1 (11) 
 2014 Jul–Sep 1.71 (5) 
 2014 Jul–Oct 1.2–1.7 (12) 
Sierra Leone 2014 Mar–Aug 2.5 (10) 
 2014 Jun–Jul 1.4 (11) 
 2014 Jul–Sep 2.02 (5) 
 2014 Jul–Oct 1.3–1.5 (12,13) 
Liberia 2014 Mar–Aug 1.59 (10) 
 2014 Jun–Jul 1.7 (11) 
 2014 Jul–Sep 1.83 (5) 
 
 
 
 
Technical Appendix Table 2. Parameters used in the model for the 2 transmission scenarios for Ebola virus disease* 
Parameter Guinea, early 2014 Partial control 
Reproduction no. for index cases, Rm 7 (k = 1.6) 2.5 (k = ) 
Reproduction no. for secondary cases within cluster, Rw 0.66 (k = 0.19) 0.66 (k = 0.19) 
Incubation period, d, mean ± SD 9.1 ± 7.3 9.1 ± 7.3 
Time from onset to reporting, d, mean ± SD  7.5 ± 10.4 3.9 ± 2.6 
Duration of infectiousness, d, mean ± SD 6.4 ± 5.3 5.3 ± 4.3 
Proportion of persons within a cluster who are vaccinated, % 70 70 
Vaccine efficacy, % 80–95 80–95 
Vaccination ring size, mean ± SD 80 ± 20 80 ± 20 
*The fitted dispersion parameter k for the negative binomial distributions is given along with reproduction numbers. We assumed that 
incubation period, time from onset to reporting, and duration of infectiousness followed a gamma distribution. 
 
 
 
Technical Appendix Table 3. Estimate doses required for elimination of Ebola virus disease with a ring vaccination strategy in the 
partial control scenario* 
Probability of case missed No. doses required (95% CI) 
10% 382 (175–822) 
20% 533 (216–1,440) 
30% 774 (265–2,900) 
40% 1,220 (329–6,760) 
*Outbreaks started with 5 index cases and 80% vaccine efficacy. 
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Technical Appendix Figure 1. Fitted distributions of reproduction numbers for effectiveness of ring 
vaccination as control strategy for Ebola virus disease. A) Cumulative distribution of secondary cases 
generated by index cases in transmission chains in Conakry, Guinea, March–August 2014 (4). Blue line 
indicates fitted negative binomial distribution, blue circles indicate values of the distribution at integer 
intervals, and black diamonds indicate data. B) Secondary cases generated by cases within clusters in 
Conakry. C) Secondary cases generated by nonindex cases in Liberia cluster. 
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Technical Appendix Figure 2. Proportion of weekly new cases of Ebola virus disease in Guinea in 2015 
that were not a known contact of an existing case, and were not part of an existing transmission chain. 
Points show expected proportion, and lines show 95% binomial CIs. Data were obtained from the World 
Health Organization (16). 
  
 Page 9 of 12 
 
 
Technical Appendix Figure 3. Model schematic for effectiveness of ring vaccination as control strategy 
for Ebola virus disease. A) Index cases generate an average of Rm secondary cases. B) Secondary cases 
within cluster have a lower reproduction number (Rw). C) There is a probability ρ that a secondary case 
will be missed and go on to seed a new transmission cluster. D) Once vaccination takes effect, the 
reproduction number for cases within the cluster decreases to Rv. 
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Technical Appendix Figure 4. Overall reproduction number in different scenarios for effectiveness of 
ring vaccination as control strategy for Ebola virus disease. A) Mean overall reproduction number across 
1,000 simulated outbreaks in the Conakry, Guinea, transmission scenario. Red lines indicate no 
vaccination, green lines indicate ring vaccination, blue lines indicate mass vaccination, solid lines indicate 
outbreaks that started with 1 index case, and dashed lines indicate outbreaks that started with 5 index 
cases. Vaccine has 80% efficacy in the model. B) Mean reproduction number in the partial control 
scenario. 
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Technical Appendix Figure 5. Effectiveness of vaccination strategies under different transmission 
scenarios, when vaccine has 95% efficacy, as control strategy for Ebola virus disease. A) Proportion of 
simulations that led to a large outbreak (defined as >500 clusters) in the Conakry, Guinea, transmission 
scenario. Red lines indicate no vaccination, green lines indicate ring vaccination, blue lines indicate mass 
vaccination, solid lines indicate outbreaks that started with 1 index case, and dashed lines indicate 
outbreaks that started with 5 index cases. We simulated 1,000 outbreaks and calculated the proportion 
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that resulted in >500 clusters. When the space between the red and green lines is large, it suggests that 
ring vaccination would provide substantial additional value over standard public health control measures 
alone. B) Proportion of simulations that led to a large outbreak in the partial control scenario. 
 
Technical Appendix Figure 6. Chains of transmission of Ebola virus disease generated in a simulated 
outbreak starting with 2 infected persons under the partial control scenario. Black points indicate the 
index case within each cluster, and arrows indicate routes of transmission. Within each cluster, we 
assumed there was a 15% probability that a secondary case would not be included in the existing chain, 
and would instead seed a new cluster (these missed links are not shown). 
